Cargando…
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction
AIMS: Endothelin-1 (ET-1) is a potent vasoconstrictor peptide linked to vascular diseases through a common intronic gene enhancer [(rs9349379-G allele), chromosome 6 (PHACTR1/EDN1)]. We performed a multimodality investigation into the role of ET-1 and this gene variant in the pathogenesis of coronar...
Autores principales: | Ford, Thomas J, Corcoran, David, Padmanabhan, Sandosh, Aman, Alisha, Rocchiccioli, Paul, Good, Richard, McEntegart, Margaret, Maguire, Janet J, Watkins, Stuart, Eteiba, Hany, Shaukat, Aadil, Lindsay, Mitchell, Robertson, Keith, Hood, Stuart, McGeoch, Ross, McDade, Robert, Yii, Eric, Sattar, Naveed, Hsu, Li-Yueh, Arai, Andrew E, Oldroyd, Keith G, Touyz, Rhian M, Davenport, Anthony P, Berry, Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557475/ https://www.ncbi.nlm.nih.gov/pubmed/31972008 http://dx.doi.org/10.1093/eurheartj/ehz915 |
Ejemplares similares
-
Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders
por: Ford, Thomas J., et al.
Publicado: (2019) -
1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)
por: Ford, Thomas J., et al.
Publicado: (2020) -
Systemic microvascular dysfunction in microvascular and vasospastic angina
por: Ford, Thomas J, et al.
Publicado: (2018) -
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial()()
por: Ford, Thomas J., et al.
Publicado: (2018) -
Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial
por: Hennigan, Barry, et al.
Publicado: (2020)